Transient neonatal diabetes mellitus is associated with a recurrent (R201H) KCNJ11 (KIR6.2) mutation
- PMID: 16205880
- DOI: 10.1007/s00125-005-1958-1
Transient neonatal diabetes mellitus is associated with a recurrent (R201H) KCNJ11 (KIR6.2) mutation
Similar articles
-
Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.Pediatr Diabetes. 2008 Jun;9(3 Pt 1):236-9. doi: 10.1111/j.1399-5448.2007.00316.x. Epub 2008 Jan 24. Pediatr Diabetes. 2008. PMID: 18221420
-
Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation.Diabetes Res Clin Pract. 2011 Jan;91(1):e1-3. doi: 10.1016/j.diabres.2010.09.027. Epub 2010 Nov 5. Diabetes Res Clin Pract. 2011. PMID: 21056492
-
Diabetes treatment in two pregnant women with permanent neonatal diabetes mellitus due to a KCNJ11 mutation.Diabet Med. 2020 Nov;37(11):1956-1958. doi: 10.1111/dme.14363. Epub 2020 Jul 20. Diabet Med. 2020. PMID: 32634858 No abstract available.
-
Successful transition from insulin to sulfonylurea therapy in a patient with monogenic neonatal diabetes owing to a KCNJ11 F333L [corrected] mutation.Diabetes Care. 2013 Dec;36(12):e201. doi: 10.2337/dc13-1690. Diabetes Care. 2013. PMID: 24265373 Free PMC article. Review. No abstract available.
-
[Neonatal diabetes mellitus].Arq Bras Endocrinol Metabol. 2008 Mar;52(2):181-7. doi: 10.1590/s0004-27302008000200005. Arq Bras Endocrinol Metabol. 2008. PMID: 18438528 Review. Portuguese.
Cited by
-
The molecular mechanisms and pharmacotherapy of ATP-sensitive potassium channel gene mutations underlying neonatal diabetes.Pharmgenomics Pers Med. 2010;3:145-61. doi: 10.2147/PGPM.S6969. Epub 2010 Nov 24. Pharmgenomics Pers Med. 2010. PMID: 23226049 Free PMC article.
-
Mutations in the ABCC8 gene encoding the SUR1 subunit of the KATP channel cause transient neonatal diabetes, permanent neonatal diabetes or permanent diabetes diagnosed outside the neonatal period.Diabetes Obes Metab. 2007 Nov;9 Suppl 2(Suppl 2):28-39. doi: 10.1111/j.1463-1326.2007.00772.x. Diabetes Obes Metab. 2007. PMID: 17919176 Free PMC article.
-
Future Roadmaps for Precision Medicine Applied to Diabetes: Rising to the Challenge of Heterogeneity.J Diabetes Res. 2018 Nov 27;2018:3061620. doi: 10.1155/2018/3061620. eCollection 2018. J Diabetes Res. 2018. PMID: 30599002 Free PMC article. Review.
-
Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene.Diabetologia. 2006 Sep;49(9):2210-3. doi: 10.1007/s00125-006-0329-x. Epub 2006 Jul 1. Diabetologia. 2006. PMID: 16816952 No abstract available.
-
Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype.Diabetologia. 2006 Jun;49(6):1190-7. doi: 10.1007/s00125-006-0246-z. Epub 2006 Apr 12. Diabetologia. 2006. PMID: 16609879
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases